Companies to explore

0 results

    No published company or research matches your search. Try a name or ticker.

    Verdict: Invest

    Română
    NASDAQ · United States

    Intel (INTC)

    Semiconductors

    UnderperformAvoid
    $89.85
    Close
    Oct 16, 2026
    -5.79% last session
    Reported revenue
    $16.13 bn
    Q2 2026
    Annual revenue growth
    25.4%
    Q2 2026
    Operating margin
    11.1%
    Q2 2026
    Reported P/E
    —
    2026-10-14
    PRICE PERFORMANCE

    1.Share price

    $98.12+$62.49 (+175.39%)from period start
    One year of daily closes$154$109$65$21Oct 25Jan 26Apr 26Jul 26Oct 26

    Daily closes, adjusted for stock splits. Price return excludes dividends. Hover or tap to explore.

    2.Company news

    View all
    Market moves
    IntelINTC

    Intel Falls 5.3% and Trails the Market

    Intel’s manufacturing comeback faces tests of customer demand and factory economics as semiconductor shares retreat.

    $107.08-5.34%
    Earnings results
    IntelINTC

    Intel’s stronger operations still leave an earnings gap

    The June-ended fiscal quarter brought stronger revenue and a return to operating profit against the same fiscal quarter of the prior year. A substantial net loss shows why the rebuilding effort still needs scrutiny.

    $104.70-2.22%
    OUR VERDICT

    3.Our verdict

    We would stay away at this price.

    The analyst targets or the existing business concerns do not support an attractive entry at this price.

    Assessed at $95.37 · 12-month horizon

    Analyst price targets · 12 months

    Published analyst targets, compared with our dated share price.

    Average target
    $118.05
    Price potential
    +23.8%
    Analysts
    49
    Low–high range
    $80.00$200.00
    Historical SPY reference · 5 years
    +11.6%
    Average target versus SPY hurdle
    12.2 pp
    Buy threshold below
    $99.52
    RESEARCH AT PUBLICATION

    4.Investment case at publication

    Intel’s operating recovery meets a harder earnings test

    Stronger sales and positive operating profit give Intel’s rebuilding effort substance, but the reported net loss keeps the recovery incomplete.

    Intel’s established processor business provides a foundation for its product and manufacturing renewal. The business case depends on sustaining operating profitability, translating sales into cash and making manufacturing investment productive without overburdening the balance sheet.

    1. Revenue and operating profitability improved against the same fiscal quarter of the prior year, supporting the operating recovery.

    2. Negative other non-operating income left Intel with a substantial consolidated net loss despite positive operating income.

    3. The June-ended fiscal quarter generated cash after gross equipment purchases, but manufacturing investment and long-term obligations remain central tests.

    5.Latest quarter

    Intel’s June-ended fiscal quarter showed a stronger operating business than the same fiscal quarter of the prior year. Revenue rose, and operating income turned positive from a loss.

    That progress did not reach the bottom line. Negative other non-operating income accompanied a substantial consolidated net loss, separating the operating recovery from the result shareholders ultimately received.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Reported revenueQ2 2026$16.13 bn
    Annual revenue growthQ2 202625.4%
    Reported operating incomeQ2 2026$1.8 bn
    Operating marginQ2 202611.1%
    Profit per share, after dilutionQ2 2026-$2.16

    6.The business

    Intel designs and manufactures processors for personal computers and data centers.

    We like Intel’s opportunity to turn its processor franchise into the engine of a manufacturing comeback. Its established place in PCs and servers gives the rebuilding effort a real foundation. Better products and a reinvigorated Intel Foundry are the clearest opportunities to make that foundation count.

    Intel Products develops chips, while Intel Foundry is the manufacturing business Intel is seeking to renew. That distinction matters: product success and manufacturing execution are related, but consolidated results do not establish the profitability of either business separately.

    7.Growth

    Reported revenue in the June-ended fiscal quarter increased against the same fiscal quarter of the prior year. This strengthens the evidence that Intel’s operating business is recovering.

    Intel earns revenue from its semiconductor business serving PC and data-center markets. The supplied consolidated statements do not identify which products or customer markets drove the sales increase, so the growth cannot be attributed to a particular segment.

    Revenue history

    $ bn
    Revenue
    Revenue historyConsolidated reported quarterly revenue; compare the same fiscal quarter across years. Unit: $ bn.$17.1$12.8$8.5$4.3$0Q3 2023 · Revenue: $14.16 bnQ4 2023 · Revenue: $15.41 bnQ1 2024 · Revenue: $12.72 bnQ2 2024 · Revenue: $12.83 bnQ3 2024 · Revenue: $13.28 bnQ4 2024 · Revenue: $14.26 bnQ1 2025 · Revenue: $12.67 bnQ2 2025 · Revenue: $12.86 bnQ3 2025 · Revenue: $13.65 bnQ4 2025 · Revenue: $13.67 bnQ1 2026 · Revenue: $13.58 bnQ2 2026 · Revenue: $16.13 bnQ3 2023Q1 2024Q3 2024Q2 2025Q4 2025Q2 2026Revenue historyConsolidated reported quarterly revenue; compare the same fiscal quarter across years. Unit: $ bn.$17.1$12.8$8.5$4.3$0Q3 2023 · Revenue: $14.16 bnQ4 2023 · Revenue: $15.41 bnQ1 2024 · Revenue: $12.72 bnQ2 2024 · Revenue: $12.83 bnQ3 2024 · Revenue: $13.28 bnQ4 2024 · Revenue: $14.26 bnQ1 2025 · Revenue: $12.67 bnQ2 2025 · Revenue: $12.86 bnQ3 2025 · Revenue: $13.65 bnQ4 2025 · Revenue: $13.67 bnQ1 2026 · Revenue: $13.58 bnQ2 2026 · Revenue: $16.13 bnQ3 2023Q1 2025Q2 2026

    Consolidated reported quarterly revenue; compare the same fiscal quarter across years.

    View chart data
    Revenue history
    PeriodRevenue ($ bn)
    Q3 2023$14.16
    Q4 2023$15.41
    Q1 2024$12.72
    Q2 2024$12.83
    Q3 2024$13.28
    Q4 2024$14.26
    Q1 2025$12.67
    Q2 2025$12.86
    Q3 2025$13.65
    Q4 2025$13.67
    Q1 2026$13.58
    Q2 2026$16.13

    8.Profitability

    Operating margin turned positive against a negative margin in the same fiscal quarter of the prior year. Intel retained operating profit from its sales rather than reporting an operating loss.

    The reported history also shows uneven profitability. Sustained positive margins would provide stronger evidence of a durable business recovery than the current quarter alone.

    Operating margin

    %
    Operating margin
    Operating marginReported consolidated operating income divided by revenue. Missing provider fields remain unavailable. Unit: %.24-1-26-50-75Q3 2023 · Operating margin: -0.06 %Q4 2023 · Operating margin: 16.78 %Q1 2024 · Operating margin: -8.4 %Q2 2024 · Operating margin: -15.3 %Q3 2024 · Operating margin: -68.18 %Q4 2024 · Operating margin: 2.89 %Q1 2025 · Operating margin: -2.38 %Q2 2025 · Operating margin: -24.7 %Q3 2025 · Operating margin: 5 %Q4 2025 · Operating margin: 4.24 %Q1 2026 · Operating margin: -23.1 %Q2 2026 · Operating margin: 11.14 %Q3 2023Q1 2024Q3 2024Q2 2025Q4 2025Q2 2026Operating marginReported consolidated operating income divided by revenue. Missing provider fields remain unavailable. Unit: %.24-1-26-50-75Q3 2023 · Operating margin: -0.06 %Q4 2023 · Operating margin: 16.78 %Q1 2024 · Operating margin: -8.4 %Q2 2024 · Operating margin: -15.3 %Q3 2024 · Operating margin: -68.18 %Q4 2024 · Operating margin: 2.89 %Q1 2025 · Operating margin: -2.38 %Q2 2025 · Operating margin: -24.7 %Q3 2025 · Operating margin: 5 %Q4 2025 · Operating margin: 4.24 %Q1 2026 · Operating margin: -23.1 %Q2 2026 · Operating margin: 11.14 %Q3 2023Q1 2025Q2 2026

    Reported consolidated operating income divided by revenue. Missing provider fields remain unavailable.

    View chart data
    Operating margin
    PeriodOperating margin (%)
    Q3 2023-0.06
    Q4 202316.78
    Q1 2024-8.4
    Q2 2024-15.3
    Q3 2024-68.18
    Q4 20242.89
    Q1 2025-2.38
    Q2 2025-24.7
    Q3 20255
    Q4 20254.24
    Q1 2026-23.1
    Q2 202611.14

    9.Earnings

    Intel’s reported diluted earnings per share became more negative than in the same fiscal quarter of the prior year, despite the improvement in operating income over that baseline.

    Massive’s consolidated statements report negative other non-operating income alongside the net loss. The available fields do not explain the underlying items, so they cannot be dismissed as temporary or treated as evidence of weaker product demand.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Other non-operating incomeQ2 2026-$12.63 bn
    Reported consolidated net incomeQ2 2026-$10.85 bn
    Average shares, including potential dilutionQ2 20265.1 bn shares

    Reported diluted EPS

    $
    Diluted EPS
    Reported diluted EPSThe published provider EPS field. No ADR, currency or adjusted-earnings conversion is inferred. Unit: $.$1.2-$0.1-$1.5-$2.8-$4.1Q3 2023 · Diluted EPS: $0.07Q4 2023 · Diluted EPS: $0.63Q1 2024 · Diluted EPS: -$0.09Q2 2024 · Diluted EPS: -$0.38Q3 2024 · Diluted EPS: -$3.88Q4 2024 · Diluted EPS: -$0.03Q1 2025 · Diluted EPS: -$0.19Q2 2025 · Diluted EPS: -$0.67Q3 2025 · Diluted EPS: $0.9Q4 2025 · Diluted EPS: -$0.12Q1 2026 · Diluted EPS: -$0.73Q2 2026 · Diluted EPS: -$2.16Q3 2023Q1 2024Q3 2024Q2 2025Q4 2025Q2 2026Reported diluted EPSThe published provider EPS field. No ADR, currency or adjusted-earnings conversion is inferred. Unit: $.$1.2-$0.1-$1.5-$2.8-$4.1Q3 2023 · Diluted EPS: $0.07Q4 2023 · Diluted EPS: $0.63Q1 2024 · Diluted EPS: -$0.09Q2 2024 · Diluted EPS: -$0.38Q3 2024 · Diluted EPS: -$3.88Q4 2024 · Diluted EPS: -$0.03Q1 2025 · Diluted EPS: -$0.19Q2 2025 · Diluted EPS: -$0.67Q3 2025 · Diluted EPS: $0.9Q4 2025 · Diluted EPS: -$0.12Q1 2026 · Diluted EPS: -$0.73Q2 2026 · Diluted EPS: -$2.16Q3 2023Q1 2025Q2 2026

    The published provider EPS field. No ADR, currency or adjusted-earnings conversion is inferred.

    View chart data
    Reported diluted EPS
    PeriodDiluted EPS ($)
    Q3 2023$0.07
    Q4 2023$0.63
    Q1 2024-$0.09
    Q2 2024-$0.38
    Q3 2024-$3.88
    Q4 2024-$0.03
    Q1 2025-$0.19
    Q2 2025-$0.67
    Q3 2025$0.9
    Q4 2025-$0.12
    Q1 2026-$0.73
    Q2 2026-$2.16

    10.Cash flow

    For the reported June-ended fiscal quarter, operating cash flow was positive and exceeded gross cash purchases of property, plant and equipment. Against the same fiscal quarter of the prior year, operating cash flow increased and gross purchases declined, leaving positive cash after those purchases rather than a shortfall.

    For the trailing twelve months ended at the June fiscal quarter-end, operating cash flow also exceeded gross cash equipment purchases. This longer window shows that investment still absorbed much of the cash generated by operations.

    The cash-after-purchases measure is calculated from Massive’s reported fields, not Intel-defined free cash flow. It excludes equipment sales, intangible investments, leases and noncash commitments, so it is not a complete measure of funding available to shareholders.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Cash generated by operationsTTM 2026-06-27$14.94 bn
    Cash after investmentsTTM 2026-06-27$2.83 bn
    Cash generated by operationsQ2 2026$7.01 bn
    Building and equipment investmentsQ2 2026$1.23 bn
    Cash after investmentsQ2 2026$5.78 bn

    Cash generated versus cash invested

    $ bn
    Operating cash flowGross cash PPE purchasesOCF less gross PPE purchases
    Cash generated versus cash investedMassive reported quarterly operating cash flow less gross cash PPE purchases, calculated in code. PPE sales, intangible investments, leases and noncash commitments are excluded. This is separate from a broader issuer-defined productive-assets cash measure. Missing fields remain unavailable. Unit: $ bn.$8$4.4$0.8-$2.8-$6.4Q3 2024 · Operating cash flow: $4.05 bnQ4 2024 · Operating cash flow: $3.17 bnQ1 2025 · Operating cash flow: $0.81 bnQ2 2025 · Operating cash flow: $2.05 bnQ3 2025 · Operating cash flow: $2.55 bnQ4 2025 · Operating cash flow: $4.29 bnQ1 2026 · Operating cash flow: $1.1 bnQ2 2026 · Operating cash flow: $7.01 bnQ3 2024 · Gross cash PPE purchases: $6.46 bnQ4 2024 · Gross cash PPE purchases: $5.83 bnQ1 2025 · Gross cash PPE purchases: $6.2 bnQ2 2025 · Gross cash PPE purchases: $2.53 bnQ3 2025 · Gross cash PPE purchases: $2.43 bnQ4 2025 · Gross cash PPE purchases: $3.49 bnQ1 2026 · Gross cash PPE purchases: $4.96 bnQ2 2026 · Gross cash PPE purchases: $1.23 bnQ3 2024 · OCF less gross PPE purchases: -$2.4 bnQ4 2024 · OCF less gross PPE purchases: -$2.67 bnQ1 2025 · OCF less gross PPE purchases: -$5.39 bnQ2 2025 · OCF less gross PPE purchases: -$0.48 bnQ3 2025 · OCF less gross PPE purchases: $0.12 bnQ4 2025 · OCF less gross PPE purchases: $0.8 bnQ1 2026 · OCF less gross PPE purchases: -$3.87 bnQ2 2026 · OCF less gross PPE purchases: $5.78 bnQ3 2024Q4 2024Q2 2025Q3 2025Q1 2026Q2 2026Cash generated versus cash investedMassive reported quarterly operating cash flow less gross cash PPE purchases, calculated in code. PPE sales, intangible investments, leases and noncash commitments are excluded. This is separate from a broader issuer-defined productive-assets cash measure. Missing fields remain unavailable. Unit: $ bn.$8$4.4$0.8-$2.8-$6.4Q3 2024 · Operating cash flow: $4.05 bnQ4 2024 · Operating cash flow: $3.17 bnQ1 2025 · Operating cash flow: $0.81 bnQ2 2025 · Operating cash flow: $2.05 bnQ3 2025 · Operating cash flow: $2.55 bnQ4 2025 · Operating cash flow: $4.29 bnQ1 2026 · Operating cash flow: $1.1 bnQ2 2026 · Operating cash flow: $7.01 bnQ3 2024 · Gross cash PPE purchases: $6.46 bnQ4 2024 · Gross cash PPE purchases: $5.83 bnQ1 2025 · Gross cash PPE purchases: $6.2 bnQ2 2025 · Gross cash PPE purchases: $2.53 bnQ3 2025 · Gross cash PPE purchases: $2.43 bnQ4 2025 · Gross cash PPE purchases: $3.49 bnQ1 2026 · Gross cash PPE purchases: $4.96 bnQ2 2026 · Gross cash PPE purchases: $1.23 bnQ3 2024 · OCF less gross PPE purchases: -$2.4 bnQ4 2024 · OCF less gross PPE purchases: -$2.67 bnQ1 2025 · OCF less gross PPE purchases: -$5.39 bnQ2 2025 · OCF less gross PPE purchases: -$0.48 bnQ3 2025 · OCF less gross PPE purchases: $0.12 bnQ4 2025 · OCF less gross PPE purchases: $0.8 bnQ1 2026 · OCF less gross PPE purchases: -$3.87 bnQ2 2026 · OCF less gross PPE purchases: $5.78 bnQ3 2024Q3 2025Q2 2026

    Massive reported quarterly operating cash flow less gross cash PPE purchases, calculated in code. PPE sales, intangible investments, leases and noncash commitments are excluded. This is separate from a broader issuer-defined productive-assets cash measure. Missing fields remain unavailable.

    View chart data
    Cash generated versus cash invested
    PeriodOperating cash flow ($ bn)Gross cash PPE purchases ($ bn)OCF less gross PPE purchases ($ bn)
    Q3 2024$4.05$6.46-$2.4
    Q4 2024$3.17$5.83-$2.67
    Q1 2025$0.81$6.2-$5.39
    Q2 2025$2.05$2.53-$0.48
    Q3 2025$2.55$2.43$0.12
    Q4 2025$4.29$3.49$0.8
    Q1 2026$1.1$4.96-$3.87
    Q2 2026$7.01$1.23$5.78

    11.Balance sheet

    At the June fiscal quarter-end, cash and short-term investments provided a liquidity cushion. Current borrowings were smaller than those liquid resources, but noncurrent debt and capital lease obligations represented a substantial financing burden.

    Intel’s manufacturing renewal requires spending on physical assets. Operating cash generation helps fund that work, while existing debt and lease obligations make investment discipline important. The available statements do not identify new financing transactions or their terms.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Cash and readily available funds2026-06-27$12.87 bn
    Short-term investments2026-06-27$16.85 bn
    Short-term debt2026-06-27$1.99 bn
    Long-term debt and leases2026-06-27$48.55 bn

    12.Valuation

    The current analyst targets and SPY comparison are shown in Our verdict.

    View the current assessment

    13.What we are watching

    Watch whether Intel sustains revenue growth and positive operating margins against the same fiscal quarters of the prior year. Product development and manufacturing renewal need to show up in repeatable operating results.

    The next tests are the explanation for non-operating losses, cash generated after clearly defined investment spending, and the capacity to meet financing obligations. Evidence of Intel Foundry’s execution would help distinguish a durable rebuilding effort from an uneven recovery.